For a few years now, the concept of Human 2.O has been very present in industry. Among the lines of work of Human 2.0, perhaps the best known is that of supporting the capabilities that humans have. Thus, we can talk about increasing human cognitive capabilities (example - augmented reality) and also physical capabilities (example -exoskeletons). And this last case is the one that we are going to evaluate in this study. The exoskeleton market was valued at USD 354.22 million in 2021, and it is expected to reach USD 1620.04 million in 2027, registering a CAGR of 12.5% during the forecast period (2022-2027). The development and production of exoskeletons requires the collaboration of experts from different fields, including engineers, medical professionals and designers. It is a task undertaken by specialized companies that focus on developing advanced exoskeletons that meet the needs of users. And finally, with all this analysis we have to think about the future of exoskeletons in the healthcare sector. Are they really going to satisfy the current needs of workers in the sector? Can their costs be assumed by health organizations? What will happen to the possible rejection of their use by patients? This and other questions must be answered in a very short period of time.
No takes yet. Share an insight, caveat, or question.
Gustavo Rosal López (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: